# Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma

> **NCT04307277** · PHASE3 · RECRUITING · sponsor: **Institut Claudius Regaud** · enrollment: 600 (estimated)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Standard of care + chemotherapy
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT04307277
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-09
- **Primary completion:** 2032-10
- **Final completion:** 2032-10
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04307277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04307277, "Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04307277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*